Stage IVC Oropharyngeal Squamous Cell Carcinoma

9 clinical trials · Condition

Record	Firm	Date
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma (NCT03422536)	University of Arizona	2017-12-05
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery (NCT03342911)	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	2017-11-13
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer (NCT02827838)	Wake Forest University Health Sciences	2017-01-01
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer (NCT02388932)	Case Comprehensive Cancer Center	2015-03-03
Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer (NCT02254278)	NRG Oncology	2014-10-01
Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT02196168)	National Cancer Institute (NCI)	2014-03-01
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer (NCT01267240)	National Cancer Institute (NCI)	2010-12-01
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385)	National Cancer Institute (NCI)	2010-11-01

Every clearance here is in the API, with alerts when new ones post.